New shot tested to regrow hair in autoimmune condition
NCT ID NCT07029204
Summary
This early-stage study is testing a new way to deliver a medication called cyclosporine directly into bald patches caused by alopecia areata, an autoimmune hair loss condition. The goal is to see if localized injections are safe and can help regrow hair while avoiding the side effects linked to taking the drug by mouth. About 12 participants will receive injections in two similar patches—one with the drug and one with a placebo—over 12 weeks to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, Davis - Dermatology Department
RECRUITINGSacramento, California, 95816, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.